株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

次世代シークエンシング市場:製品タイプ (装置・消耗品・サービス)、用途 (研究・臨床)、手法 (サンガー法・NGS)

Next Generation Sequencing Market by Product Type (Instrumentation, Consumables, Services), Application (Research, Clinical), by Method (Sanger, Next-Generation) and by Geographic Region

発行 Kalorama Information 商品コード 324189
出版日 ページ情報 英文 216 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.09円で換算しております。
Back to Top
次世代シークエンシング市場:製品タイプ (装置・消耗品・サービス)、用途 (研究・臨床)、手法 (サンガー法・NGS) Next Generation Sequencing Market by Product Type (Instrumentation, Consumables, Services), Application (Research, Clinical), by Method (Sanger, Next-Generation) and by Geographic Region
出版日: 2018年04月16日 ページ情報: 英文 216 Pages
概要

当レポートでは、世界の次世代シークエンシング市場について調査し、産業構造と動向、セグメント・地域別の分析 (装置・消耗品・サービス) 、全体・セグメント別の収益、研究 vs. 臨床利用、疾患分類別の分析と予測、および主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

イントロダクション

  • 概要:次世代シーケンシング技術
  • NGS技術のメリット
  • NGS技術を用いたシーケンシングの共通タイプ
  • NGS市場における主要動向
  • 臨床NGS試験

産業構造

  • 競合サマリー
  • 競合分析
  • 参入障壁
  • 競合要因
  • 注目の市場イベント
  • 大きな市場動向

市場収益・予測

  • 市場概要
  • 市場全体の予測
  • NGS装置市場セグメント
  • NGS消耗品市場セグメント
  • シーケンシング市場:研究 vs. 臨床利用
  • シークエンシング手法/アプリケーション
  • 臨床シークエンシング市場

企業プロファイル:次世代シークエンシング企業

  • 10x Genomics, Inc.
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies Inc.
  • Base4 Innovation Ltd
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BGI
  • BioDynami
  • Bioo Scientific Corporation
  • Bio-Rad Laboratories
  • Cergentis B.V.
  • Depixus SAA
  • Direct Genomics Co., Ltd.
  • DNA Electronics Ltd.
  • Dovetail Genomics, LLC
  • Epigentek
  • Fluidigm
  • GenapSys, Inc.
  • HTG Molecular Diagnostics
  • iGenomX
  • Illumina, Inc.
  • Kapa Biosystems
  • Lasergen, Inc.
  • Lucigen Corporation
  • MCLAB
  • MilliporeSigma
  • Mission Bio, Inc.
  • NanoString Technologies
  • New England Biolabs, Inc.
  • NuGen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • NuGen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Roche
  • Seqwell, Inc.
  • Stratos Genomics Inc.
  • Swift Biosciences
  • Takara Bio USA (Clontech Laboratories)
  • Thermo Fisher Scientific
目次
Product Code: KLI15656980

Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends)

The promise of DNA sequencing has attracted many companies, researchers, and investors. The sequencing market is now large and growing rapidly, finding numerous commercial applications in many fields, including clinical diagnostics, drug discovery and development, agriculture, forensics and consumer genomics. Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends) provides a market snapshot and a total market forecast, including:

  • Global Sequencing Market Estimated Breakdown, 2017 (%) (Sanger Sequencing, Next Generation Sequencing)
  • Global Next Generation Sequencing (NGS) Market Estimated Breakdown, 2017 (%) (Instruments, Consumables, Services)
  • Worldwide Sequencing Market Product Revenues (Total Market, including Instruments, Consumables, and Services), 2017 and 2022
  • Global Sequencing Market, 2016-2022 (Sanger Sequencing Technologies, Next Generation Sequencing Technologies, Total)
  • Global Sequencing Market, 2016-2022 (Sanger Sequencing, Next Generation Sequencing, Total market)
  • Global NGS Instrumentation Market, 2016-2022
  • Global NGS Consumables Market, 2016-2022
  • Global Next Generation Sequencing (NGS) Market, 2016-2022 (Services, Instruments, Consumables, Total market)

Geographic Distribution in NGS Markets

Revenue growth in NGS markets is expected to be driven primarily by the increasing use of this technology in clinical applications, as well as by the growing applications of NGS in numerous other scientific and commercial areas. The report forecasts this growth across geographic regions, including the following data points:

  • Global NGS Market, Estimated Breakdown by Geographies, 2017 (%) (USA, Germany, UK, China, Others)
  • Global NGS Market Forecast by Geographic Region ($ millions), 2016-2022 (World, United States, Europe, APAC, Rest of World)

Sequencing Market - Research versus Clinical Use

The initial customers for DNA sequencing platforms were researchers, such as those in academic, government, and other non-profit institutions, as well as pharmaceutical and other companies performing various types of research. DNA sequencing will continue to be widely used by researchers, and the use of sequencing for research applications is expected to continue to grow as the instrumentation becomes more affordable and user-friendly, and scientists become more aware and comfortable with NGS technologies. In addition, as the applications of sequencing are expanding beyond academic research into commercial areas such as clinical diagnostics, consumer genomics, forensics, and agriculture, additional commercial organizations have entered this field. The report reviews the sequencing market in terms of research versus clinical use:

  • Clinical Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022
  • Research Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022

Clinical Sequencing Market - Disease Indications

As the development of NGS-based clinical diagnostics has intensified in recent years, companies active in the NGS market have introduced various solutions to accelerate the development of clinical applications, including sample and library preparation reagent kits optimized for low input and degraded DNA samples, or for types of samples commonly used in clinical practice, such as blood and saliva. Other approaches include technologies that reduce the overall number of steps involved in library preparation, eliminate the sample preparation entirely, enable single tube chemistries, or permit the multiplexing of large numbers of samples. Next Generation Sequencing Markets provides a breakdown of the current clinical sequencing market by disease category:

  • Estimated Clinical Sequencing Market Breakdown by Disease Category, 2017, Percentage (Oncology, Reproductive health, Rare/inherited disorders, Others)
  • Projected Clinical Sequencing Market Breakdown by Disease Category, 2022, Percentage (Oncology, Reproductive health, Rare/inherited disorders, Infectious diseases, Others)

Industry Structure and Trends

The global market for NGS technologies has been characterized by a rapid evolution of sequencing technologies and decreasing sequencing prices, which has made NGS more accessible to a growing base of users and affordable for various commercial applications. Also, the global market for NGS technologies is experiencing several notable trends that have a significant effect on its participants, as well as on the overall market growth.

In recent years, the introduction of numerous new products intended for a broad range of applications has expanded and accelerated the adoption of NGS in many fields beyond pure sequencing, including clinical diagnostics, drug development, agriculture, forensics, consumer genomics, and food and pathogen testing. The report outlines NGS industry structure and analyses in detail the relevant trends as well as their estimated impact on market growth, including the following:

  • NGS Technologies Industry Structure Summary, 2018 (Number and Type of Participating Companies, Key Players, Main Types of Customers, Market Concentration, Key Competitive Factors, Barriers to Entry, Differentiation Strategies, Notable Mergers and Acquisitions)
  • Significant Trends in the NGS Technologies Market, 2018

Competitive Analysis

More than 100 players participate in NGS markets, from large multinational corporations to small, niche life sciences companies, developing and commercializing various NGS products. Next Generation Sequencing Markets profiles selected players in the market for NGS technologies, including:

  • 10x Genomics, Inc.
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies Inc.
  • Base4 Innovation Ltd
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BGI
  • BioDynami
  • Bioo Scientific Corporation
  • Bio-Rad Laboratories
  • Cergentis B.V.
  • Depixus SAA
  • Direct Genomics Co., Ltd.
  • DNA Electronics Ltd.
  • Dovetail Genomics, LLC
  • Epigentek
  • Fluidigm
  • GenapSys, Inc.
  • HTG Molecular Diagnostics
  • iGenomX
  • Illumina, Inc.
  • Kapa Biosystems
  • Lasergen, Inc.
  • Lucigen Corporation
  • MCLAB
  • MilliporeSigma
  • Mission Bio, Inc.
  • NanoString Technologies
  • New England Biolabs, Inc.
  • NuGen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Roche
  • Seqwell, Inc.
  • Stratos Genomics Inc.
  • Swift Biosciences
  • Takara Bio USA (Clontech Laboratories)
  • Thermo Fisher Scientific

Table of Contents

Executive Summary

  • Sequencing Overview
  • Industry Overview
  • Market Overview
    • Table Worldwide Sequencing Market Product Revenues (Total Market, including Instruments, Consumables, and Services), 2017 and 2022 (millions USD)
  • Future Prospects in the Sequencing Market
    • Table Global Sequencing Market ($ millions), 2016-2022
    • Table Global Sequencing Market ($ millions), 2016-2022
    • Table Global Next Generation Sequencing (NGS) Market ($ millions), 2016-2022

Introduction

  • Overview - Next Generation Sequencing Technologies
    • Table Selected Currently Marketed NGS Platforms, 2018
  • Advantages of NGS Technologies
    • Table Comparison of NGS and Sanger Sequencing
  • Common Types of Sequencing using NGS Technologies
    • Table Types of Sequencing Using NGS Technologies
  • Major Trends in the NGS Market
  • Clinical NGS Testing
    • Table FDA-approved NGS-based In Vitro Diagnostics Tests, 2017

Industry Structure

  • Competitive Summary
    • Table NGS Technologies Industry Structure Summary, 2018
  • Competitive Analysis
    • Table Industry Structure Summary - Selected Players in the Market for NGS Technologies, 2018
  • Barriers to Entry
  • Competitive Factors
  • Notable Market Events
  • Significant Market Trends
    • Table Significant Trends in the NGS Technologies Market, 2018

Market Revenues and Forecast

  • Market Snapshot
    • Table Global Sequencing Market Estimated Breakdown, 2017 (%)
    • Table Global NGS Market Estimated Breakdown, 2017 (%)
  • Total Market Forecast
    • Table Global Sequencing Market ($ millions), 2016-2022
    • Table Global Sequencing Market ($ millions), 2016-2022
  • NGS Instrumentation Market Segment
    • Competitive Analysis
    • Revenue Forecast
    • Table Global NGS Instrumentation Market ($ millions), 2016-2022
  • NGS Consumables Market Segment
    • Competitive Analysis
    • Revenue Forecast
    • Table Global NGS Consumables Market ($ millions), 2016-2022
  • Next Generation Sequencing Market - Geographic Distribution
    • Market Snapshot
    • Table Global NGS Market, Estimated Breakdown by Geographies, 2017 (%) (USA, Germany, UK, China, Others)
    • Revenue Forecast
    • Table Global NGS Market Forecast by Geographic Region ($ millions), 2016-2022
    • Table Global NGS Market Forecast by Geographic Region ($ millions), 2016-2022
  • Sequencing Market - Research versus Clinical Use
    • Table Percent of End Users (Academic & Government versus Commercial, Non-Profit & Hospital), 2014, 2015, and 2018 (estimated)
    • Table Clinical Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022
    • Table Research Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022
  • Sequencing Methods/Applications
    • Table NGS Sequencing Market - Estimated Breakdown by Types of Sequencing (%) (2017)
  • Clinical Sequencing Market - Disease Indications
    • Table Estimated Clinical Sequencing Market Breakdown by Disease Category, 2017, Percentage
    • Table Projected Clinical Sequencing Market Breakdown by Disease Category, 2022, Percentage

Company Profiles - Next Generation Sequencing Companies

  • 10x Genomics, Inc.
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies Inc.
  • Base4 Innovation Ltd
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BGI
  • BioDynami
  • Bioo Scientific Corporation
    • DNA Sequencing
    • RNA Sequencing
    • Small RNA Sequencing
    • Targeted Sequencing
    • Epigenetics
    • Metagenomics
  • Bio-Rad Laboratories
  • Cergentis B.V.
  • Depixus SAA
  • Direct Genomics Co., Ltd.
  • DNA Electronics Ltd.
  • Dovetail Genomics, LLC
  • Epigentek
  • Fluidigm
  • GenapSys, Inc.
  • HTG Molecular Diagnostics
  • iGenomX
  • Illumina, Inc.
    • Sequencing Platforms
    • HiSeq line of Products
    • NovaSeq Line of Products
    • MiSeq and NextSeq Platforms
    • MiniSeq
    • iSeq 100
    • Automation Systems for Library Preparation
    • Library Preparation/ Sequencing Kits
    • Linked-Read Technologies
    • Clinical and Translational Research Use Only (RUO) Products
    • In Vitro Diagnostic (IVD) Products
  • Kapa Biosystems
  • Lasergen, Inc.
  • Lucigen Corporation
  • MCLAB
  • MilliporeSigma
  • Mission Bio, Inc.
  • NanoString Technologies
  • New England Biolabs, Inc.
    • NGS Targeted Panels
    • DNA Sequencing
    • RNA Sequencing
  • NuGen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
    • SOLiD(R) Small RNA Solution
    • Sanger Sequencing Instrumentation and Consumables
    • Sequencing Instrumentation
    • Sample Preparation Automation
    • Sequencing Consumables
    • Intellectual Property Disputes
  • Pacific Biosciences of California, Inc.
    • Sequencing Instrumentation
    • Consumables
    • Future Developments
  • Promega Corporation
  • QIAGEN N.V.
  • Roche
  • Seqwell, Inc.
  • Stratos Genomics Inc.
  • Swift Biosciences
  • Takara Bio USA (Clontech Laboratories)
  • Thermo Fisher Scientific
    • NGS Instrumentation
    • Ion PGM
    • Ion Proton
    • Ion S5/ S5 XL
    • Automated Sample Preparation Systems
    • Clinical Assays
Back to Top